Omeprazole Arrow (Omeprazole)

Omeprazole acts by irreversibly binding to the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, on the secretory surface of parietal cells. This inhibition blocks the final step of gastric acid secretion, leading to a sustained increase in gastric pH and providing an environment that supports mucosal healing and symptom control.

The appropriate dose of Omeprazole Arrow is determined by the prescribing clinician based on the specific indication, severity of disease, patient age, renal and hepatic function, and other individual factors. Healthcare professionals set the dosage regimen according to current clinical guidelines and patient needs.

Omeprazole is classified as pregnancy category B in many regions, indicating that animal studies have not shown risk, but there are limited controlled human studies. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any required import documentation.

Omeprazole belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established efficacy and safety profile, making it a common first‑line option for acid‑related disorders.

Omeprazole Arrow should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product in a dry, well‑ventilated area and avoid exposure to high humidity or temperature extremes to maintain stability.

Omeprazole Arrow is supplied as an oral dosage form that is swallowed whole with water, typically before a meal. Patients should follow the prescribing clinician’s instructions regarding timing, frequency and whether the tablet should be taken with or without food.

Serious adverse reactions, although rare, include Clostridioides difficile‑associated colitis, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, acute interstitial nephritis, and significant electrolyte disturbances like hypomagnesemia. Patients should be monitored for these events, especially during prolonged therapy.

Omeprazole Arrow is contraindicated in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in those taking medications that have a critical interaction, such as clopidogrel, unless alternative therapy is selected.